JPMorgan Chase & Co. grew its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 5.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,416,305 shares of the company’s stock after buying an additional 66,986 shares during the period. JPMorgan Chase & Co. owned approximately 2.68% of Nu Skin Enterprises worth $87,443,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. raised its position in shares of Nu Skin Enterprises by 1.8% during the second quarter. BlackRock Inc. now owns 6,805,093 shares of the company’s stock worth $427,632,000 after purchasing an additional 121,562 shares during the period. Vanguard Group Inc. raised its position in shares of Nu Skin Enterprises by 0.8% during the second quarter. Vanguard Group Inc. now owns 6,060,437 shares of the company’s stock worth $380,838,000 after purchasing an additional 48,805 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Nu Skin Enterprises by 6.5% during the second quarter. Dimensional Fund Advisors LP now owns 1,067,875 shares of the company’s stock worth $67,106,000 after purchasing an additional 64,767 shares during the period. Bank of New York Mellon Corp raised its position in shares of Nu Skin Enterprises by 22.1% during the second quarter. Bank of New York Mellon Corp now owns 885,257 shares of the company’s stock worth $55,628,000 after purchasing an additional 160,495 shares during the period. Finally, Wasatch Advisors Inc. raised its position in Nu Skin Enterprises by 0.3% in the 3rd quarter. Wasatch Advisors Inc. now owns 640,595 shares of the company’s stock valued at $39,384,000 after buying an additional 2,199 shares during the last quarter. Hedge funds and other institutional investors own 77.54% of the company’s stock.
Nu Skin Enterprises, Inc. (NUS) traded up $0.23 during trading hours on Tuesday, hitting $66.57. The company’s stock had a trading volume of 478,300 shares, compared to its average volume of 665,273. The firm has a market cap of $3,492.80, a price-to-earnings ratio of 23.44, a price-to-earnings-growth ratio of 2.41 and a beta of 1.57. Nu Skin Enterprises, Inc. has a 52-week low of $46.35 and a 52-week high of $68.50. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th will be given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.16%. The ex-dividend date is Thursday, November 16th. Nu Skin Enterprises’s dividend payout ratio (DPR) is 52.75%.
In other news, insider Joseph Y. Chang sold 36,503 shares of Nu Skin Enterprises stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $62.24, for a total transaction of $2,271,946.72. Following the completion of the transaction, the insider now directly owns 66,563 shares in the company, valued at approximately $4,142,881.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Daniel W. Campbell sold 4,607 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $62.48, for a total value of $287,845.36. Following the transaction, the director now owns 63,753 shares of the company’s stock, valued at $3,983,287.44. The disclosure for this sale can be found here. Insiders have sold a total of 73,207 shares of company stock worth $4,585,949 in the last ninety days. Insiders own 5.20% of the company’s stock.
A number of brokerages recently issued reports on NUS. Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $62.00.
WARNING: “Nu Skin Enterprises, Inc. (NUS) Holdings Boosted by JPMorgan Chase & Co.” was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.chaffeybreeze.com/2017/12/05/nu-skin-enterprises-inc-nus-holdings-boosted-by-jpmorgan-chase-co.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.